Patel, A., Shah, V., Parekh, D., Batayneh, O., Desai, D., Elzein, S. (2025). Real-world comparison of BTKi monotherapy and fixed-duration BTKi–Venetoclax for first line treatment of chronic lymphocytic leukemia patients without TP53 mutations or IGHV rearrangement. Blood. https://doi.org/10.1182/blood-2025-7435